Skip to main content

Merrimack Pharmaceuticals Inc

MACKDelisted May 10, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001274792

Merrimack Pharmaceuticals Inc was delisted on May 10, 2024; its insiders filed their last Form 4 on Dec 28, 2023; 70 institutions reported holding it in 13F filings for Q1 2024, worth $137.1M in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in Merrimack Pharmaceuticals Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
−1 vs. Q2 2022
Shares held
8.01M
−51.8K (−0.6%) vs. Q2 2022
Total value
$30.0M
−$17.9M (−37.4%) vs. Q2 2022
New holders
2
8 more added
Sold out
3
14 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MACK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 41 institutions
Q1 2021: 43 institutionsQ2 2021: 42 institutionsQ3 2021: 38 institutionsQ4 2021: 37 institutionsQ1 2022: 40 institutionsQ2 2022: 42 institutionsQ3 2022: 41 institutionsQ4 2022: 47 institutionsQ1 2023: 50 institutionsQ2 2023: 62 institutionsQ3 2023: 63 institutionsQ4 2023: 67 institutionsQ1 2024: 70 institutionsQ2 2024: 12 institutionsQ3 2024: 2 institutionsQ4 2024: 2 institutionsQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ3 2022: $30.0M
Q1 2021: $49.8MQ2 2021: $50.3MQ3 2021: $37.1MQ4 2021: $29.3MQ1 2022: $49.4MQ2 2022: $48.0MQ3 2022: $30.0MQ4 2022: $86.6MQ1 2023: $91.0MQ2 2023: $98.5MQ3 2023: $104.4MQ4 2023: $124.9MQ1 2024: $137.1MQ2 2024: $5.32MQ3 2024: $0Q4 2024: $370.7KQ1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding MACK and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20251$0
Q4 20242$370.7K
Q3 20242$0
Q2 202412$5.32M
Q1 202470$137.1M
Q4 202367$124.9M
Q3 202363$104.4M
Q2 202362$98.5M
Q1 202350$91.0M
Q4 202247$86.6M
Q3 202241$30.0M
Q2 202242$48.0M
Q1 202240$49.4M
Q4 202137$29.3M
Q3 202138$37.1M
Q2 202142$50.3M
Q1 202143$49.8M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Merrimack Pharmaceuticals Inc; share changes are against Q2 2022.

Institutions holding MACK in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Newtyn Management, LLC1,767,094$6.63M1.45%+9,089+0.5%Added
22NW, LP1,231,014$4.62M2.61%−10,882−0.9%Reduced
Western Standard LLC1,172,463$4.40M5.03%−97,095−7.6%Reduced
Point72 Asset Management, L.P.1,100,994$4.13M0.02%+765,886+228.5%Added
Vanguard Group Inc607,804$2.28M0.00%−400−0.1%Reduced
Dimensional Fund Advisors LP472,301$1.77M0.00%−4,407−0.9%Reduced
Nantahala Capital Management, LLC429,596$1.61M0.16%−61,913−12.6%Reduced
Sepio Capital, LP294,545$1.10M0.11%−21,768−6.9%Reduced
BlackRock Inc.206,783$775.0K0.00%−932−0.4%Reduced
Wittenberg Investment Management, Inc.188,694$708.0K0.30%00.0%Unchanged
Yakira Capital Management, Inc.115,821$434.0K0.06%00.0%Unchanged
Geode Capital Management, LLC100,808$378.0K0.00%00.0%Unchanged
State Street Corp46,556$175.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP41,618$156.0K0.00%+2,871+7.4%Added
Bank of New York Mellon Corp40,951$153.0K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC34,200$128.0K0.00%−25,000−42.2%Reduced
Northern Trust Corp23,980$90.0K0.00%+177+0.7%Added
Two Sigma Investments, LP21,519$81.0K0.00%−3,400−13.6%Reduced
Belvedere Trading LLC20,052$77.0K0.08%+20,052New
Two Sigma Advisers, LP18,681$70.0K0.00%−300−1.6%Reduced
Brown Advisory Inc15,029$56.0K0.00%00.0%Unchanged
Citadel Advisors LLC13,718$51.0K0.00%−2,493−15.4%Reduced
Group One Trading, L.P.11,930$45.0K0.00%−3,625−23.3%Reduced
Simplex Trading, LLC8,692$32.0K0.00%−27,776−76.2%Reduced
Morgan Stanley6,514$25.0K0.00%−844−11.5%Reduced
Mascoma Wealth Management LLC5,000$19.0K0.01%00.0%Unchanged
UBS Group AG5,196$19.0K0.00%+3,952+317.7%Added
Royal Bank of Canada3,539$13.0K0.00%+31+0.9%Added
Webster Bank, N. A.3,055$11.0K0.00%00.0%Unchanged
Bank of America Corp1,536$6.00K0.00%00.0%Unchanged
Baldwin Brothers Inc500$2.00K0.00%00.0%Unchanged
Kayne Anderson Rudnick Investment Management LLC300$1.00K0.00%00.0%Unchanged
Sandy Spring Bank300$1.00K0.00%00.0%Unchanged
Rise Advisors, LLC272$1.00K0.00%00.0%Unchanged
Federated Hermes, Inc.91$1.00K0.00%00.0%Unchanged
TSFG, LLC160$1.00K0.00%00.0%Unchanged
Wells Fargo & Company239$1.00K0.00%+117+95.9%Added
Tower Research Capital LLC (TRC)185$1.00K0.00%+125+208.3%Added
AdvisorNet Financial, Inc20$00.00%00.0%Unchanged
City State Bank25$00.00%00.0%Unchanged
FMR LLC1$00.00%+1New
Bronte Capital Management Pty Ltd.0$00.00%−578,313−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−14,142−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−800−100.0%Sold out